ArticleContrast media & molecular imaging2022
Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- Prediction of sentinel lymph node status in patients with early breast cancer using breast imaging as an alternative to surgical staging-a systematic review and meta-analysis.Systematic reviews · 2025Pooled it
- Diagnostic performance of DCE-MRI radiomics in predicting axillary lymph node metastasis in breast cancer patients: A meta-analysis.PloS one · 2024Pooled it
- Intratumoral and peritumoral-based radiomics for assessment of lymphovascular invasion in invasive breast cancer: model development and validation.Translational cancer research · 2026Article
- Dynamic nomogram for predicting axillary lymph node metastasis in breast cancer based on MRI analysis and the platelet-to-lymphocyte ratio (PLR).Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Prediction of pathological complete response to neoadjuvant therapy in breast cancer using deep learning with multi-modal radiological image and biopsy whole slide images: a two-center study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Habitat imaging based on DCE-MRI for differentiating luminal and non-luminal subtypes of breast cancer: a two-center study.Frontiers in oncology · 2026Article
- Uncertainty-Aware Machine Learning for Predicting Axillary Lymph Node Metastasis Using Breast MRI.Breast cancer (Dove Medical Press) · 2026Article
- MRI-Based Intratumoral and Multi-Range Peritumoral Radiomics for Predicting Axillary Lymph Node Metastasis in Breast Cancer.International journal of general medicine · 2026Article
- Radiomics integrated with machine and deep learning analysis of T2-weighted and arterial-phase T1-weighted Magnetic Resonance Imaging for non-invasive detection of metastatic axillary lymph nodes in breast cancer.La Radiologia medica · 2025Article
- Predicting breast cancer response to neoadjuvant therapy by integrating radiomic and deep-learning features from early-and-peak phases of DCE-MRI.BMC cancer · 2025Article
- Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using Radiomics Features of Voxel-Wise DCE-MRI Time-Intensity-Curve Profile Maps.Biomedicines · 2025Article
- Intratumoral and peritumoral radiomics based on 2D ultrasound imaging in breast cancer was used to determine the optimal peritumoral range for predicting KI-67 expression.Journal of ultrasound · 2025Article
- Article
- Utilizing intratumoral and peritumoral ultrasound radiomics for predicting KRAS gene mutation status in rectal cancer patients.Journal of applied clinical medical physics · 2025Article
- The value of multiparametric MRI radiomics and machine learning in predicting preoperative Ki-67 expression level in breast cancer.BMC medical imaging · 2025Article
- Preoperative prediction of HER2 expression and sentinel lymph node status in breast cancer using a mammography radiomics model.Frontiers in oncology · 2025Article
- Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study.Quantitative imaging in medicine and surgery · 2024Article
- Prediction of axillary lymph node metastasis using a magnetic resonance imaging radiomics model of invasive breast cancer primary tumor.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
- Molecular subtypes of breast cancer identified by dynamically enhanced MRI radiomics: the delayed phase cannot be ignored.Insights into imaging · 2024Article
- Assessment of the axilla in women with early-stage breast cancer undergoing primary surgery: a review.World journal of surgical oncology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the value of preoperative prediction of breast cancer axillary lymph node metastasis based on intratumoral and peritumoral dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) radiomics nomogram. Results: The intratumoral combined peritumoral radiomics signature, which was composed of fifteen ALN status-related features, showed the best predictive performance and was associated with ALNM in both the training and validation cohorts ( Conclusion: The intratumoral combined peritumoral radiomics model derived from DCE-MRI showed great predictive value for ALNM and may help to improve clinical decision-making for BC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.